MedTrace Logo

Biofeedback for Women With Dyssynergic Defecation (DD)

NCT07622732 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 58

Last updated 2026-08-21

No results posted yet for this study

Summary

This research aimed to compare the effect of Biofeedback (BFB) versus Lifestyle management in form of stretching positions and patient's education position of defecation, in addition to rectal massage, and anal dilators among Dyssynergic Defecation (DD) in Females. It is common and affects up to one half of patients with chronic constipation. This acquired behavioral problem is due to the inability to coordinate the abdominal and pelvic floor muscles to evacuate stools

Conditions

  • Dyssenergic Defecation
  • Straining, Hard Stools, Incomplete Evacuation

Interventions

OTHER

Lifestyle management in form of stretching positions and patient's education position of defecation

1. Stretching Positions: \*Child's Pose\*\* Reverse Kegel Exercises \*\*\*Supine Piriformis Stretch. 2. Education Defecation Position: patient sit with her knees positioned higher than hips, use a small footstool. Lean forward from the hips and rest your forearms on thighs. 3. Rectal Massage: Using a water-based lubricant and a clean, gloved finger, therapist can gently massage the internal anal sphincter to encourage it to relax. 4. Anal Dilators: patient lie on her side or back with pillows under knees. Apply a generous amount of water-based lubricant to both the dilator and anal area. Ask patient to gently bear down as if passing gas and insert the tip. Pause if she feel the muscle contract or guard, ask her to focus on breathing, and wait for the muscle to soften before inserting it further.Once fully inserted, ask her to breathe in deeply to distend her belly, then exhale while maintaining abdominal distention. Visualize the pelvic floor dropping.

Sponsors & Collaborators

  • Ahram Canadian University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
35 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-06-15
Primary Completion
2026-10-15
Completion
2026-11-01

Countries

  • Egypt

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07622732 on ClinicalTrials.gov